Show” correspondent Al Madrigal returned on Thursday night with a stinging message about immigrants in the United States.

CEO Bill Sibold hailed 2024 as a "transformational year" for Madrigal Pharmaceuticals, but Wall Street isn't as enthusiastic ...

Shares of Madrigal Pharmaceuticals (NASDAQ: MDGL) were sinking 13.3% lower as of 11:11 a.m. ET on Monday. Madrigal reported ...

An estimates-beating set of preliminary financial numbers and two bullish analyst updates weren't enough to lift Madrigal ...

There’s a lot of drama going on at the restaurant. There always is,” the SUR manager tells PEOPLE of the new SURvers ...

Madrigal Pharmaceuticals announced its preliminary Q4 and full-year results. The company topped the official Wall Street estimates, but seems to have missed the so-called "whisper numbers." ...

With parts of Los Angeles County still smoldering from wildfires, the expected rain this weekend would seem like a welcome ...

Madrigal Pharmaceuticals, Inc.（纳斯达克代码：MDGL）的高级副总裁兼首席制药开发官Robert E. Waltermire最近出售了442股公司普通股。根据 InvestingPro 的分析，这家市值63.9亿美元、流动性强（流动比率为5.98）的生物制药公司尽管处于增长阶段，但仍保持着稳健的财务状况。这些股票以平均每股273.41美元的价格售出，总计约120,84 ...

Analyst Mayank Mamtani from B.Riley Financial reiterated a Hold rating on Madrigal Pharmaceuticals (MDGL – Research Report) and keeping the ...

根据提交给美国证券交易委员会的Form 4文件显示，Madrigal Pharmaceuticals Inc. (NASDAQ:MDGL)的总法律顾问Kelley Shannon ...

Madrigal Pharmaceuticals (NASDAQ:MDGL – Get Free Report)‘s stock had its “market outperform” rating reaffirmed by equities ...